tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Financial Statements

Compare
8 Followers

Chimeric Therapeutics Ltd. Financial Overview

Chimeric Therapeutics Ltd.'s market cap is currently AU$11.17M. The company's EPS TTM is AU$-0.012; its P/E ratio is ―; Chimeric Therapeutics Ltd. is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 7.46MAU$ 4.51MAU$ 2.62MAU$ 2.65KAU$ 0.00
Gross ProfitAU$ 7.45MAU$ 3.54MAU$ 1.67MAU$ -844.31KAU$ 0.00
Operating IncomeAU$ -12.31MAU$ -29.49MAU$ -13.82MAU$ -15.11MAU$ -64.01K
EBITDAAU$ -11.30MAU$ -24.02MAU$ -13.62MAU$ -14.00MAU$ 0.00
Net IncomeAU$ -12.53MAU$ -25.92MAU$ -14.62MAU$ -15.11MAU$ -64.01K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 3.05MAU$ 5.37MAU$ 18.38MAU$ 22.41MAU$ 100.00
Total AssetsAU$ 15.27MAU$ 22.38MAU$ 34.88MAU$ 36.50MAU$ 100.00
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 34.01K
Net DebtAU$ -3.05MAU$ -5.37MAU$ -18.38MAU$ -22.41MAU$ 33.91K
Total LiabilitiesAU$ 12.80MAU$ 16.71MAU$ 9.17MAU$ 11.37MAU$ 64.01K
Stockholders' EquityAU$ 2.47MAU$ 5.66MAU$ 25.71MAU$ 25.13MAU$ -63.91K
Cash Flow
Free Cash FlowAU$ 10.11KAU$ -16.43MAU$ -13.69MAU$ -14.15MAU$ -34.01K
Operating Cash FlowAU$ -7.54MAU$ -16.32MAU$ -13.15MAU$ -8.84MAU$ -34.01K
Investing Cash FlowAU$ 0.00AU$ -112.19KAU$ -564.88KAU$ -5.30MAU$ 0.00
Financing Cash FlowAU$ 8.26MAU$ 263.68KAU$ 9.50MAU$ 36.54MAU$ 34.11K
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

Chimeric Therapeutics Ltd. Debt to Assets

Chimeric Therapeutics Ltd. Cash Flow

Chimeric Therapeutics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis